131 related articles for article (PubMed ID: 34738162)
1. Predictors for the utilization of social service counseling by prostate cancer patients.
Breidenbach C; Ansmann L; Sibert NT; Wesselmann S; Dieng S; Carl EG; Feick G; Stoklossa C; Taubert A; Pomery A; Beyer B; Blana A; Brock M; Distler F; Enge M; Gaber AA; Gilfrich C; Hinkel A; Kaftan B; Knoll T; Kunath F; Oostdam SJ; Peters I; Polat B; Schrodi V; Zengerling F; Kowalski C
Support Care Cancer; 2022 Mar; 30(3):2327-2339. PubMed ID: 34738162
[TBL] [Abstract][Full Text] [Related]
2. Use of psycho-oncological services by prostate cancer patients: A multilevel analysis.
Breidenbach C; Roth R; Ansmann L; Wesselmann S; Dieng S; Carl EG; Feick G; Oesterle A; Bach P; Beyer B; Borowitz R; Erdmann J; Kunath F; Oostdam SJ; Tsaur I; Zengerling F; Kowalski C
Cancer Med; 2020 Jun; 9(11):3680-3690. PubMed ID: 32233081
[TBL] [Abstract][Full Text] [Related]
3. Use of social service counseling by cancer patients: an analysis of quality assurance data of 6339 breast cancer patients from 13 certified centers in Germany treated between 2015 and 2017.
Breidenbach C; Wesselmann S; Sibert NT; Ortmann O; Blankenburg K; Stoklossa C; Gebauer G; Dos Santos Guilherme M; Lindner C; Peschel S; Schad F; Strecker P; Rieger L; Ferencz J; Dieng S; Kowalski C
BMC Cancer; 2021 Jun; 21(1):671. PubMed ID: 34090379
[TBL] [Abstract][Full Text] [Related]
4. Incorporating psychosocial care into routine oncological care: Insights into challenges and strategies from certified cancer centers' audit data.
Breidenbach C; Kowalski C; Ansmann L; Schult S; Sibert NT; Neupert I; Zimmermann T; Wesselmann S
Psychooncology; 2022 Aug; 31(8):1331-1339. PubMed ID: 35353412
[TBL] [Abstract][Full Text] [Related]
5. Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer.
Wilt TJ; MacDonald R; Rutks I; Shamliyan TA; Taylor BC; Kane RL
Ann Intern Med; 2008 Mar; 148(6):435-48. PubMed ID: 18252677
[TBL] [Abstract][Full Text] [Related]
6. Frequency of psycho-oncologic and social service counseling in cancer centers relative to center site and hospital characteristics: Findings from 879 center sites in Germany, Austria, Switzerland, and Italy.
Kowalski C; Ferencz J; Singer S; Weis I; Wesselmann S
Cancer; 2016 Nov; 122(22):3538-3545. PubMed ID: 27481151
[TBL] [Abstract][Full Text] [Related]
7. Population-Based Assessment of Determining Treatments for Prostate Cancer.
Chamie K; Williams SB; Hu JC
JAMA Oncol; 2015 Apr; 1(1):60-7. PubMed ID: 26182305
[TBL] [Abstract][Full Text] [Related]
8. [Treatment mapping of prostate cancer in DVPZ prostate centers in Germany].
Berges R; Ebert T; Schafhauser W; Schultze-Seemann W; Braun M; Herden J; Weib P; Garcia Schürmann M; Reimann M; Bornhof C; Oberpenning F; Baur P; Zumbé J; Gronau E; Diederichs W; Brinkman OA; Goepel M; Göll A; Hoefner K; Kriegmair M; Laabs S; Planz B; Platz G; Heidenreich A
Urologe A; 2015 Nov; 54(11):1546, 1548-54. PubMed ID: 26518302
[TBL] [Abstract][Full Text] [Related]
9. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
Kawakami J; Cowan JE; Elkin EP; Latini DM; DuChane J; Carroll PR;
Cancer; 2006 Apr; 106(8):1708-14. PubMed ID: 16544313
[TBL] [Abstract][Full Text] [Related]
10. Social service counseling in cancer centers certified by the German Cancer Society.
Kowalski C; Ferencz J; Weis I; Adolph H; Wesselmann S
Soc Work Health Care; 2015; 54(4):307-19. PubMed ID: 25905764
[TBL] [Abstract][Full Text] [Related]
11. Active Surveillance for Men with Intermediate Risk Prostate Cancer.
Agrawal V; Ma X; Hu JC; Barbieri CE; Nagar H
J Urol; 2021 Jan; 205(1):115-121. PubMed ID: 32658588
[TBL] [Abstract][Full Text] [Related]
12. Use of androgen deprivation therapy as salvage treatment after primary therapy for clinically localized prostate cancer.
Fu AZ; Tsai HT; Haque R; Ulcickas Yood M; Van Den Eeden SK; Cassidy-Bushrow AE; Zhou Y; Keating NL; Smith MR; Aaronson DS; Potosky AL
World J Urol; 2016 Dec; 34(12):1611-1619. PubMed ID: 27084777
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Radical Prostatectomy Versus Radiation and Androgen Deprivation Therapy Strategies as Primary Treatment for High-risk Localized Prostate Cancer: A Systematic Review and Meta-analysis.
Greenberger BA; Zaorsky NG; Den RB
Eur Urol Focus; 2020 Mar; 6(2):404-418. PubMed ID: 31813810
[TBL] [Abstract][Full Text] [Related]
14. Mortality and Androgen Deprivation Therapy as Salvage Treatment for Biochemical Recurrence after Primary Therapy for Clinically Localized Prostate Cancer.
Fu AZ; Tsai HT; Haque R; Yood MU; Cassidy-Bushrow AE; Van Den Eeden SK; Keating NL; Smith MR; Zhou Y; Aaronson DS; Potosky AL
J Urol; 2017 Jun; 197(6):1448-1454. PubMed ID: 28007467
[TBL] [Abstract][Full Text] [Related]
15. Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from cancer of the prostate strategic urologic research endeavor.
Grossfeld GD; Li YP; Lubeck DP; Broering JM; Mehta SS; Carroll PR
J Urol; 2002 Aug; 168(2):530-5. PubMed ID: 12131303
[TBL] [Abstract][Full Text] [Related]
16. Radical prostatectomy or watchful waiting in early prostate cancer.
Bill-Axelson A; Holmberg L; Garmo H; Rider JR; Taari K; Busch C; Nordling S; Häggman M; Andersson SO; Spångberg A; Andrén O; Palmgren J; Steineck G; Adami HO; Johansson JE
N Engl J Med; 2014 Mar; 370(10):932-42. PubMed ID: 24597866
[TBL] [Abstract][Full Text] [Related]
17. Health-related quality of life in active surveillance and radical prostatectomy for low-risk prostate cancer: a prospective observational study (HAROW - Hormonal therapy, Active Surveillance, Radiation, Operation, Watchful Waiting).
Ansmann L; Winter N; Ernstmann N; Heidenreich A; Weissbach L; Herden J
BJU Int; 2018 Sep; 122(3):401-410. PubMed ID: 29603553
[TBL] [Abstract][Full Text] [Related]
18. Use of additional treatment for prostate cancer after radical prostatectomy, radiation therapy, androgen deprivation, or watchful waiting.
Berge V; Thompson T; Blackman D
Scand J Urol Nephrol; 2007; 41(3):198-203. PubMed ID: 17469027
[TBL] [Abstract][Full Text] [Related]
19. A comparative assessment of active surveillance for localized prostate cancer in the community versus tertiary care referral center.
Becker A; Seiler D; Kwiatkowski M; Kluth LA; Schnell D; Graefen M; Schlomm T; Fisch M; Recker F; Weissbach L; Chun FK
World J Urol; 2014 Aug; 32(4):891-7. PubMed ID: 24820259
[TBL] [Abstract][Full Text] [Related]
20. Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH database.
Keto CJ; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Freedland SJ
BJU Int; 2012 Aug; 110(4):492-8. PubMed ID: 22094083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
